Beauty

Decode Age

SEASON 3 : Episode 14

BRAND

Decode Age

COMPANY NAME

Centenarians Life Sciences Private Limited

FOUNDERS

Parth Amin, Darshit Patel, Rakesh Somani

ORIGNAL ASK

1 crore for 1.25% equity at the valuation of Rs. 80 crores

DEAL

1 crore for 2.25% equity at the valuation of Rs. 44.44 crores and 1% royalty until 1.5 crore is recouped

Introducing Decode Age’s Ca-AKG, a groundbreaking supplement designed to unlock the secrets of longevity and vitality. Delve into the world of NMN (Nicotinamide Mononucleotide) and discover its potential to revolutionize the aging process. Our product harnesses the power of Alpha Keto Glutarate (AKG), scientifically proven to reduce biological aging by up to 5 years. With the added benefit of calcium salts, Decode Age Ca-AKG supports optimal metabolic function, amplifying your body’s natural energy balance. Experience the transformative effects of Decode Age Ca-AKG and embark on a journey towards a youthful, healthier life.

decodeage.com

Amazon

Founders & their story

  • Parth Amin
  • Darshit Patel
  • Rakesh Somani

Decode Age is India’s pioneering company focused on longevity, aiming to address the universal desire to stay youthful and healthy. The company operates on three core principles: prevention, prediction, and personalization. Through a holistic approach, Decode Age offers solutions to manage age-related symptoms, predict potential health risks through biological age testing, and personalize protocols based on individual biological data to reverse the aging process. With a customer base of over 20,000 individuals, Decode Age has quickly emerged as a leader in the field since its inception in March 2023. Decode Age’s preventive measures include a range of supplements scientifically formulated to manage age-related symptoms and promote overall well-being. These supplements empower customers to take proactive steps towards maintaining their health and vitality as they age.

Central to Decode Age’s approach is the prediction of potential health risks through biological age testing and gut microbiome analysis. By understanding biological age, customers gain insights into their unique aging process, allowing for targeted interventions and personalized protocols to optimize longevity and vitality. Decode Age offers a seamless user journey for its biological age testing, starting with the convenient order of a home testing kit from the company’s website. Customers collect their saliva samples using the provided tube, which are then swiftly collected from their doorstep by the Decode Age team. Samples are processed in state-of-the-art laboratories, utilizing advanced technologies for accurate analysis.

The comprehensive DNA report generated from the home testing kit covers 180 markers, providing customers with detailed insights into their genetic makeup. Additionally, Decode Age collaborates with a UK-based lab for epigenetic testing, further enhancing the depth of analysis and predictive capabilities.

In addition to genetic analysis, Decode Age conducts proprietary stool tests in-house to analyze gut microbiome composition. This comprehensive approach enables Decode Age to tailor personalized protocols based on each customer’s unique biological data, effectively reversing the aging process and promoting lasting vitality. Decode Age’s commitment to advancing longevity science and empowering individuals to reclaim their youthfulness underscores its position as a trailblazer in the field. With age becoming merely a number and the future brimming with possibilities, Decode Age invites individuals to join the journey towards a vibrant and healthy life.

About the company

At Decode Age, they transcend the role of a mere wellness brand; they constitute a longevity ecosystem pioneering the field of longevity research in India. Their objective is to democratize the latest scientific advancements in this realm, ensuring accessibility for all. Their focus lies on offering meticulously researched products to enhance individuals’ health and well-being, positioning them as the preferred choice for those committed to extending their health span.

Their distinguishing factor lies in their groundbreaking Gut Microbiome research. Housing a cutting-edge Next-Generation Sequencing (NGS) Lab, they delve deeply into this domain. Their proficient team, specializing in bioinformatics and microbiome research, grants them a significant competitive advantage. They proudly hold the distinction of being the first company in India to provide the advanced Shotgun Gut Microbiome test, surpassing the limited 16s tests conducted by others in the field.

They adhere to a staunch commitment to honesty and transparency in their scientific and innovative endeavours, with human health at the forefront. Their offerings extend beyond mere products; they provide scientifically backed solutions tailored to individual needs. Their tests yield personalized data, their educational resources furnish unique insights, and their products cater to specific health objectives and requirements. They firmly believe that personalized, scientific wellness has the potential to greatly enhance both the quality and duration of one’s life.

Their mission mirrors their dedication to empowering individuals to lead healthier lives for longer durations. They present an array of personalized products, ranging from testing to education to supplements, meticulously crafted to support individuals at every phase of life.

Revenue

In the fiscal year 2023-24 (until October), Decode Age achieved an EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margin of 10%. This EBITDA margin specifically for supplements also stood at 10% during the same period. The company’s monthly burn rate ranged between 8 to 9 lakh rupees. Decode Age has raised a total of 1.13 crores in funding at a valuation of 60 crores. Initially, the company received an investment of 1 crore rupees.

Founders’ Ask 

1 crore for 1.25% equity at the valuation of Rs. 80 crores.

Offers:

Anupam’s offer: 1 crore for 2.5% equity at the valuation of Rs. 40 crores and 1% royalty until 1.5 crore is recouped.

Anupam’s revised offer: 1 crore for 2.25% equity at the valuation of Rs. 44.44 crores and 1% royalty until 1.5 crore is recouped.

Founder’s Counteroffer:

Offer 1: 2 crores for 1.75% equity at the valuation of 57.14 crores.

Final Deal

Anupam: 1 crore for 2.25% equity at the valuation of Rs. 44.44 crores and 1% royalty until 1.5 crore is recouped.

 

 

 

Have questions on product

Still have questions on product, bulk buying

YOU MIGHT LIKE

Coming soon